Abstract
The authors studied how COVID-19 is administered to liver transplant patients and found out that a mechanism to reduce virus virulence in infected liver transplant patients involves the use of immunosuppressant medications, to reduce the cytotoxic strain of the virus during this period. However, in the 21 patients we studied, it was clear that this contingent was constantly receiving immunosuppressive drugs, so they easily went through a period of COVID-19 infection.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
